SYNGENE

Syngene International Share PriceSyngene International

₹575.2
-4.05 (-0.7%)
  • Advice
  • Hold
As on 24 March, 2023 | 15:49 BSE: 539268 NSE: SYNGENE

Syngene International Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Syngene International

Start SIP

Syngene International Share Price

  • Over 1 Month -1.62%
  • Over 3 Month -0.64%
  • Over 6 Month 3.45%
  • Over 1 Year -4.85%

Syngene International Key Statistics

P/E Ratio 53.3
PEG Ratio 8.8
Market Cap Cr 23,091
Price to Book Ratio 7
EPS 10.4
Dividend 0.2
Relative Strength Index 51.11
Money Flow Index 49.01
MACD Signal 0.67
Average True Range 12.79

Syngene International Investment Rating

  • Master Rating:
  • Syngene Inter has an operating revenue of Rs. 2,956.60 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 19% is great, ROE of 12% is good. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around -0% and -0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 59 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 61 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Syngene International Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 787768645759
Operating Expenses Qtr Cr 556552473509
Operating Profit Qtr Cr 230216172249
Depreciation Qtr Cr 95908680
Interest Qtr Cr 141296
Tax Qtr Cr 30281931
Net Profit Qtr Cr 11010273147

Syngene International Technicals

EMA & SMA

Current Price
₹575.2
-4.05 (-0.7%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 577.92
  • 50 Day
  • 579.2
  • 100 Day
  • 581.55
  • 200 Day
  • 582.23
  • 20 Day
  • 578.74
  • 50 Day
  • 579.44
  • 100 Day
  • 589.07
  • 200 Day
  • 580.23

Syngene International Resistance and Support

PIVOT
₹580.09
Resistance
First Resistance 583.17
Second Resistance 587.09
Third Resistance 590.17
RSI 51.11
MFI 49.01
MACD Single Line 0.67
MACD 0.6
Support
First Resistance 576.17
Second Resistance 573.09
Third Resistance 569.17

Syngene International Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 455,922 24,437,419 53.6
Week 399,904 22,610,572 56.54
1 Month 425,250 23,933,054 56.28
6 Month 858,950 60,049,214 69.91

Syngene International Result Highlights

Syngene International Synopsis

NSE-Medical-Research Eqp/Svc

Syngene Internationa is involved in the business activities of Scientific research and development. Company’s Total Operating Revenue is Rs. 2601.40 Cr. and Equity Capital is Rs. 400.80 Cr. for the Year ended 31/03/2022. Syngene International Ltd. is a Public Limited Listed company incorporated on 18/11/1993 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1993PLC014937 and registration number is 014937.
Market Cap 22,937
Sales 2,958
Shares in Float 14.05
No of funds 289
Yield 0.09
Book Value 7.05
U/D Vol ratio 1.1
LTDebt / Equity 16
Alpha -0.01
Beta 0.66

Syngene International

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 64.86%64.86%70.29%
Mutual Funds 5.01%4.78%2.79%
Insurance Companies 0.32%0.17%
Foreign Portfolio Investors 16.87%16.79%14.12%
Financial Institutions/ Banks 0.01%
Individual Investors 8.57%8.82%9.03%
Others 4.37%4.57%3.77%

Syngene International Management

Name Designation
Ms. Kiran Mazumdar Shaw Non Executive Chairman
Mr. Jonathan Hunt Managing Director & CEO
Prof. Catherine Rosenberg Non Executive Director
Ms. Vinita Bali Lead Independent Director
Dr. Vijay Kuchroo Independent Director
Dr. Carl Decicco Independent Director
Ms. Sharmila Abhay Karve Independent Director
Dr. Kush Parmar Independent Director
Mr. Paul Blackburn Independent Director

Syngene International Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Syngene International MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 23945
Kotak Equity Arbitrage Fund Growth 21918
ICICI Prudential Equity Arbitrage Fund Regular Growth 11273
ICICI Prudential Long Term Equity Fund (Tax Saving) Growth 9819
Invesco India Contra Fund Growth 9348

Syngene International FAQs

What is Share Price of Syngene International ?

Syngene International share price is ₹575 As on 24 March, 2023 | 15:35

What is the Market Cap of Syngene International ?

The Market Cap of Syngene International is ₹23090.5 Cr As on 24 March, 2023 | 15:35

What is the P/E ratio of Syngene International ?

The P/E ratio of Syngene International is 53.3 As on 24 March, 2023 | 15:35

What is the PB ratio of Syngene International ?

The PB ratio of Syngene International is 7 As on 24 March, 2023 | 15:35

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number